메뉴 건너뛰기
Gut
Volumn 64, Issue 7, 2015, Pages 1181-1182
An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis
Author keywords

[No Author keywords available]
Indexed keywords

COLON RESECTION; ENDOSCOPIC MAYO SCORE; HEALING; HISTOLOGY; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME; ULCERATIVE COLITIS; FEMALE; INTESTINE MUCOSA; MALE; PATHOLOGY; PATHOPHYSIOLOGY;
EID: 84934960798     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308839     Document Type: Letter
Times cited : (56)
References (4)
  • 1
    • 84941266497 scopus 로고    scopus 로고
    • Comparing histological activity indexes in UC
    • Published Online First22Sep
    • Bressenot A, Salleron J, Bastien C, et al. Comparing histological activity indexes in UC. Gut Published Online First 22 Sep 2014. doi:10.1136/gutjnl-2014-307477
    • (2014) Gut
    • Bressenot, A.1    Salleron, J.2    Bastien, C.3
  • 2
    • 80053130407 scopus 로고    scopus 로고
    • Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
    • Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194-201.
    • (2011) Gastroenterology , vol.141 , pp. 1194-1201
    • Colombel, J.F.1    Rutgeerts, P.2    Reinisch, W.3
  • 3
    • 84876486013 scopus 로고    scopus 로고
    • Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: A multicenter experience
    • Laharie D, Filippi J, Roblin X, et al. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience. Aliment Pharmacol Ther 2013;37:998-1004.
    • (2013) Aliment Pharmacol Ther , vol.37 , pp. 998-1004
    • Laharie, D.1    Filippi, J.2    Roblin, X.3
  • 4
    • 79958228566 scopus 로고    scopus 로고
    • Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
    • Peyrin-Biroulet L, Oussalah A, Williet N, et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011;60:930-6.
    • (2011) Gut , vol.60 , pp. 930-936
    • Peyrin-Biroulet, L.1    Oussalah, A.2    Williet, N.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.